Renibus Therapeutics® (“Renibus”), a clinical-stage biotech company focusing on the prevention and treatment of cardiorenal diseases, announced today that Frank Stonebanks has been appointed as Chief Executive Officer, bringing more than 25 years of experience across healthcare and venture capital (VC) to lead Renibus in its next phase of growth. The Company also announced it has completed a $15 million extension as part of of its Series A financing, led by family offices specializing in biotech investments, closing the round at $35 million.
top of page
Recent PostsSee All
By: Steven Loeb Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While there are more startups than ever, there's
Matterworks, Inc., developers of the world's most powerful metabolomics platform, which accelerates the discovery, development, and manufacturing of biologics and gene therapies, today announces updat
Luna, the leading provider of in-home physical therapy, has teamed up with UCI Health, to expand access to patient care by providing in-home physical therapy across Orange County, California. With a f
bottom of page